Detalhe da pesquisa
1.
Long-term outcomes for ibrutinib-rituximab and chemoimmunotherapy in CLL: updated results of the E1912 trial.
Blood
; 140(2): 112-120, 2022 07 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-35427411
2.
The CLL International Prognostic Index predicts outcomes in monoclonal B-cell lymphocytosis and Rai 0 CLL.
Blood
; 138(2): 149-159, 2021 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33876228
3.
Natural history of monoclonal B-cell lymphocytosis among relatives in CLL families.
Blood
; 137(15): 2046-2056, 2021 04 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33512457
4.
DTRMWXHS-12, a novel Bruton tyrosine kinase inhibitor, in combination with everolimus and pomalidomide in patients with relapsed/refractory lymphomas: An open-label, multicenter, phase 1a/1b study.
Am J Hematol
; 98(5): 739-749, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36810799
5.
Combined ibrutinib and venetoclax for treatment of patients with ibrutinib-resistant or double-refractory chronic lymphocytic leukaemia.
Br J Haematol
; 199(2): 239-244, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35841338
6.
Ibrutinib-Rituximab or Chemoimmunotherapy for Chronic Lymphocytic Leukemia.
N Engl J Med
; 381(5): 432-443, 2019 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31365801
7.
Humoral and cellular immune responses to recombinant herpes zoster vaccine in patients with chronic lymphocytic leukemia and monoclonal B cell lymphocytosis.
Am J Hematol
; 97(1): 90-98, 2022 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34699616
8.
Atrial fibrillation in patients with chronic lymphocytic leukemia (CLL) treated with ibrutinib: risk prediction, management, and clinical outcomes.
Ann Hematol
; 100(1): 143-155, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-32488603
9.
Disease Flare During Temporary Interruption of Ibrutinib Therapy in Patients with Chronic Lymphocytic Leukemia.
Oncologist
; 25(11): 974-980, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32886416
10.
Association of polygenic risk score with the risk of chronic lymphocytic leukemia and monoclonal B-cell lymphocytosis.
Blood
; 131(23): 2541-2551, 2018 06 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29674426
11.
Clinical characteristics and outcomes of Richter transformation: experience of 204 patients from a single center.
Haematologica
; 105(3): 765-773, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31197071
12.
Tumor mutational load predicts time to first treatment in chronic lymphocytic leukemia (CLL) and monoclonal B-cell lymphocytosis beyond the CLL international prognostic index.
Am J Hematol
; 95(8): 906-917, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32279347
13.
Pembrolizumab in patients with CLL and Richter transformation or with relapsed CLL.
Blood
; 129(26): 3419-3427, 2017 06 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-28424162
14.
IGH translocations in chronic lymphocytic leukemia: Clinicopathologic features and clinical outcomes.
Am J Hematol
; 94(3): 338-345, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30575108
15.
Autoimmune cytopenias in patients with chronic lymphocytic leukaemia treated with ibrutinib in routine clinical practice at an academic medical centre.
Br J Haematol
; 183(3): 421-427, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30117139
16.
Differential transcriptomic profiling in ibrutinib-naïve versus ibrutinib-resistant Richter syndrome.
Hematol Oncol
; 40(2): 302-306, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34806797
17.
Akt inhibitor MK-2206 in combination with bendamustine and rituximab in relapsed or refractory chronic lymphocytic leukemia: Results from the N1087 alliance study.
Am J Hematol
; 92(8): 759-763, 2017 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-28402581
18.
Liver dysfunction in chronic lymphocytic leukemia: Prevalence, outcomes, and pathological findings.
Am J Hematol
; 92(12): 1362-1369, 2017 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-28940587
19.
A phase 2 study of lenalidomide, rituximab, cyclophosphamide, and dexamethasone (LR-CD) for untreated low-grade non-Hodgkin lymphoma requiring therapy.
Am J Hematol
; 92(5): 467-472, 2017 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-28230270
20.
The prognostic significance of del6q23 in chronic lymphocytic leukemia.
Am J Hematol
; 96(6): E203-E206, 2021 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33749852